Omeprazole magnesium and Speech impairment (adult) - a phase IV clinical study of FDA data
Summary:
We study 6,645 people who have side effects when taking Omeprazole magnesium. Speech impairment (adult) is found, especially among people who are female, 60+ old, have been taking the drug for 10+ years, also take Humira and have Crohn's disease.
The phase IV clinical study analyzes which people take Omeprazole magnesium and have Speech impairment (adult). It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
6,645 people reported to have side effects when taking Omeprazole magnesium.
Among them, 9 people (0.14%) have Speech impairment (adult).
What is Omeprazole magnesium?
Omeprazole magnesium has active ingredients of omeprazole magnesium. It is used in gastroesophageal reflux disease. Currently, eHealthMe is studying from 6,760 Omeprazole magnesium users.
What is Speech impairment (adult)?
Speech impairment (adult) (inability to speak (adult)) is found to be associated with 3,660 drugs and 3,465 conditions by eHealthMe. Currently, we are studying 79,047 people who have Speech impairment (adult).
Number of Omeprazole magnesium and Speech impairment (adult) reports submitted per year:
/could-omeprazole-magnesium-cause-speech-impairment-(adult).png)
Time on Omeprazole magnesium when people have Speech impairment (adult) *:
- < 1 month: 0.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 50 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 50 %
Gender of people who have Speech impairment (adult) when taking Omeprazole magnesium *:
- female: 88.89 %
- male: 11.11 %
Age of people who have Speech impairment (adult) when taking Omeprazole magnesium *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 12.5 %
- 20-29: 25.0 %
- 30-39: 0.0 %
- 40-49: 12.5 %
- 50-59: 0.0 %
- 60+: 50.0 %
Common drugs people take besides Omeprazole magnesium *:
- Humira: 3 people, 33.33%
- Levothyroxine Sodium: 2 people, 22.22%
- Plavix: 2 people, 22.22%
- Nasonex: 2 people, 22.22%
- Atenolol: 2 people, 22.22%
- Loratadine: 2 people, 22.22%
- Amlodipine: 1 person, 11.11%
- Aspirin: 1 person, 11.11%
- Codeine: 1 person, 11.11%
- Eliquis: 1 person, 11.11%
Common side effects people have besides Speech impairment (adult) *:
- Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 33.33%
- Swelling Face: 3 people, 33.33%
- Hypoaesthesia (reduced sense of touch or sensation): 2 people, 22.22%
- Hyperhidrosis (abnormally increased sweating): 2 people, 22.22%
- Diarrhea: 2 people, 22.22%
- Eyelid Function Disorder: 2 people, 22.22%
- Fatigue (feeling of tiredness): 2 people, 22.22%
- Muscle Spasms (muscle contraction): 2 people, 22.22%
- Confusional State: 2 people, 22.22%
- Cerebral Artery Embolism (sudden blocking of an artery by a clot or foreign material): 2 people, 22.22%
Common conditions people have *:
- Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 2 people, 22.22%
- Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 11.11%
- Serotonin Syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time): 1 person, 11.11%
- Sedation: 1 person, 11.11%
- Psychotic Disorder: 1 person, 11.11%
- Post-Traumatic Stress Disorder: 1 person, 11.11%
- Oculogyric Crisis (a spasmodic movement of the eyeballs into a fixed position due to medicine reaction): 1 person, 11.11%
- Neuralgia (pain in one or more nerves): 1 person, 11.11%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 11.11%
- Muscle Spasms (muscle contraction): 1 person, 11.11%
* Approximation only. Some reports may have incomplete information.
Do you take Omeprazole magnesium and have Speech impairment (adult)?
Check whether Speech impairment (adult) is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Omeprazole magnesium side effects by duration, gender and age:
- Omeprazole magnesium side effects (6,760 reports)
Speech impairment (adult) treatments and more:
- Speech impairment (adult) (79,047 reports)
Common drugs associated with Speech impairment (adult):
- Aspirin: 3,705 reports
- Tysabri: 2,437 reports
- Metformin: 2,391 reports
- Gabapentin: 2,153 reports
- Omeprazole: 2,101 reports
- Prednisone: 2,049 reports
- Lyrica: 2,035 reports
- Methotrexate: 2,015 reports
- Loraz: 1,914 reports
- Lorazepam: 1,913 reports
All the drugs that are associated with Speech impairment (adult):
- Speech impairment (adult) (3,660 drugs)
Common conditions associated with Speech impairment (adult):
- Multiple sclerosis: 6,963 reports
- High blood pressure: 3,630 reports
- Depression: 3,087 reports
- Pain: 2,677 reports
All the conditions that are associated with Speech impairment (adult):
- Speech impairment (adult) (3,465 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on omeprazole magnesium (the active ingredients of Omeprazole magnesium) and Omeprazole magnesium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Atracurium Besylate and Hyperkalemia - a second ago
- Mirtazapine and Weight Abnormal - a second ago
- Atovaquone and Levaquin drug interaction - 5 seconds ago
- Montelukast Sodium and Augmentin '125' drug interaction - 8 seconds ago
- Novorapid and Hypokalemia - 9 seconds ago
- Soy and Acetaminophen drug interaction - 11 seconds ago
- Bepreve and Alendronate Sodium drug interaction - 11 seconds ago
- Ceftriaxone and Eplerenone drug interaction - 12 seconds ago
- Sulfamethoxazole And Trimethoprim and Nausea - 21 seconds ago
- Elelyso and Retinal Detachment - 24 seconds ago